Memantine for the patients with mild cognitive impairment in Parkinson’s disease: a pharmacological fMRI study

BACKGROUND: Mild cognitive impairment in Parkinson’s disease (PD-MCI) is associated with an increased risk of cognitive decline. PD-MCI is characterized by impairments in executive function and visuospatial recognition. The visuospatial n-back test is useful for assessing both domains. The 0-back te...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawashima, Shoji, Matsukawa, Noriyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103297/
https://www.ncbi.nlm.nih.gov/pubmed/35562711
http://dx.doi.org/10.1186/s12883-022-02699-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103297/
https://www.ncbi.nlm.nih.gov/pubmed/35562711
http://dx.doi.org/10.1186/s12883-022-02699-x

Ejemplares similares